Creatine Supplement Shows Promise in Enhancing Cancer Immunotherapy
Recent research from the University of California, Los Angeles, published in iScience, has revealed that creatine, a common gym supplement, may significantly enhance the effectiveness of cancer immunotherapy. The study found that creatine acts as an energy source for dendritic cells, which are crucial in supporting and guiding killer T cells in the immune system's fight against cancer. While immunotherapies are powerful, they are only effective in 20-40% of patients. The research demonstrated that creatine supplementation could potentially improve the infrastructure supporting T cells, thereby boosting the immune response. The study involved testing creatine's effects in human cells and mouse models, showing promising results in slowing tumor growth and increasing dendritic cell activity. However, clinical trials are needed to confirm these findings in humans. 
